PD
ATXS

Point72 (DIFC)’s Astria Therapeutics ATXS Stock Holding History

Point72 (DIFC)’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.9K Buy
+2,319
New +$15.7K ﹤0.01% 881
2025
Q2 		– Sell
-3,525
Closed -$18.8K – 1549
2025
Q1 		$18.8K Buy
+3,525
New +$24.7K ﹤0.01% 1359
2024
Q3 		– Sell
-857
Closed -$7.8K – 1449
2024
Q2 		$7.8K Buy
+857
New +$8.37K ﹤0.01% 1333

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 (DIFC)'s ATXS Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Astria Therapeutics (ATXS) in Q3 2025: 2,319 shares worth $16.9K. The stake represents ﹤0.01% of the portfolio and ranks #881 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in ATXS as recently as Q1 2025.

Point72 (DIFC) first reported a position in ATXS in Q2 2024 and has held it in 3 quarters since. The position peaked at $18.8K in Q1 2025. 115 funds tracked by Wall St. Rank hold ATXS as of Q3 2025.

  • Point72 (DIFC) held 2,319 shares of Astria Therapeutics worth $16.9K as of Q3 2025.
  • Astria Therapeutics was a new Point72 (DIFC) position in Q3 2025.
  • Astria Therapeutics made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #881 holding.
  • Point72 (DIFC) first reported a position in Astria Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Astria Therapeutics position peaked at $18.8K in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Astria Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.